Evidence map›Paper›PMID 29568007›Full record

ArticleScientific reports2018

Author Correction: Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo.

Haipeng Liu, Danmei Su, Jinlong Zhang, Shuaishuai Ge, Youwei Li, Fei Wang, Michel Gravel, Anne Roulston, Qin Song, Wei Xu and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Haipeng LiuDepartment of Biochemistry & Molecular Biology, College of Life Sciences, Sichuan University, Chengdu, China.
Danmei SuDepartment of Biochemistry & Molecular Biology, College of Life Sciences, Sichuan University, Chengdu, China.
Jinlong ZhangDepartment of Biochemistry & Molecular Biology, College of Life Sciences, Sichuan University, Chengdu, China.
Shuaishuai GeDepartment of Biochemistry & Molecular Biology, College of Life Sciences, Sichuan University, Chengdu, China.
Youwei LiDepartment of Biochemistry & Molecular Biology, College of Life Sciences, Sichuan University, Chengdu, China.
Fei WangDepartment of Biochemistry & Molecular Biology, College of Life Sciences, Sichuan University, Chengdu, China.
Michel GravelLaboratory for Therapeutic Development, Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal (QC), Canada.
Anne RoulstonLaboratory for Therapeutic Development, Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal (QC), Canada.
Qin SongClover Biopharmaceuticals, Chengdu, China.
Wei XuClover Biopharmaceuticals, Chengdu, China.
Joshua G LiangClover Biopharmaceuticals, Chengdu, China.
Gordon ShoreLaboratory for Therapeutic Development, Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal (QC), Canada.
Xiaodong WangNational Institute of Biological Sciences, Beijing, China.
Peng LiangDepartment of Biochemistry & Molecular Biology, College of Life Sciences, Sichuan University, Chengdu, China. liang.peng@cloverbiopharma.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

Identifiers

PMID29568007
PMCPMC5864869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.